Navigation Links
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Date:4/18/2012

ATLANTA, April 18, 2012 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company focused in Women's Health, recently announced the appointment of Michael Sullivan as Vice President, Sales and Marketing.  Sullivan will be responsible for all sales and marketing efforts for Avion.  Avion Pharmaceuticals recently re-launched the PRENATE FAMILY™ of prenatal vitamins, newly reformulated with QUATREFOLIC®, the fourth generation of folic acid.      

Sullivan has more than 20 years of successful prescription pharmaceutical sales and marketing experience, including "start-up" expertise.  

Mike is a graduate of Neumann University and he earned his Master's in Business Administration from Frostburg State University. 

"We are thrilled to have Mike's expertise in the Women's Healthcare category as we build our PRENATE® franchise," said Mark Pugh, CEO of Avion Pharmaceuticals.   "We are looking to Mike to assist us in expanding into other therapeutic categories and advancing our brand presence in the prescription market."

About Avion Pharmaceuticals, LLC.
Avion is a specialty pharmaceutical company that develops and markets a growing portfolio of innovative, branded pharmaceutical and dietary supplement products in the Women's Health and Dermatology areas.  Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available dietary supplement products, therapeutics and late –stage development drugs to fulfill unmet medical and dietary needs.


'/>"/>
SOURCE Avion Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
2. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
3. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
4. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
7. Tibet Pharmaceuticals, Inc. Announces Intent to Go Private
8. Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
9. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
10. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
11. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)...  Former Attorney General of Louisiana , ... the law firm of Kahn Swick & Foti, LLC ("KSF"), ... Inc. (NYSE: LCI ). On ... "U.S. Charges in Generic-Drug Probe to Be Filed by Year-End," ... begun about two years ago, now spans more than a ...
(Date:12/4/2016)... , Dec. 3, 2016 Sickle cell disease ... sickle-shaped red blood cells that get stuck in veins ... stroke, organ failure, and complications leading to death. Each ... with SCD, and most of them lack access to ... only established long-term therapy for SCD, a pill called ...
(Date:12/4/2016)... A highly innovative, personalized cell-based treatment for a high-risk form of the ... from Children,s Hospital of Philadelphia today reported new ... (ALL). The physician-scientists presented findings at the annual meeting of ... . Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with First 5 ... services to more than 15,900 children 5 years old and younger and treatment services ... over a span of five years to Western University of Health Sciences, UCLA and ...
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... 02, 2016 , ... The annual time frame to change Medicare health and ... ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current ... need to make changes during this period order for their new policy to go ...
Breaking Medicine News(10 mins):